News & Updates
Filter by Specialty:
Change in serum marker levels tied to outcomes of RA-related interstitial lung disease
In rheumatoid arthritis-related interstitial lung disease (RA-ILD), change over time in the levels of serum proteins, such as matrix metallopeptidase 13 (MMP13) and C-X-C motif ligand chemokine 11 (CXCL11), predict clinical outcomes, a recent study has found. The same is true for baseline clinical factors such as patient age and rheumatoid factor.
Change in serum marker levels tied to outcomes of RA-related interstitial lung disease
19 Jun 2022Ketogenic trials with Parkinson’s disease-specific outcomes lacking
The ketogenic diet, as well as ketogenic agents, has been shown to be a promising therapeutic regimen for Parkinson’s disease (PD) in animals, but research on humans is highly heterogenous and lacking PD-specific outcomes, according to a study.
Ketogenic trials with Parkinson’s disease-specific outcomes lacking
19 Jun 2022Pandemic-caused treatment delays for cancer may aggravate psychological distress
Cancer patients who experience treatment delays due to the COVID-19 pandemic restrictions may be vulnerable to psychological distress, reports a recent China study. Effective communication from doctors and other cancer care professionals may help mitigate this effect.
Pandemic-caused treatment delays for cancer may aggravate psychological distress
18 Jun 2022Dulaglutide: A new horizon for T2D treatment in kids
A once-weekly subcutaneous dose of the GLP-1* receptor agonist dulaglutide successfully controlled glycaemic levels in youths with type 2 diabetes (T2D) being treated with lifestyle modification with or without metformin or insulin, results of the multinational, phase III AWARD-PEDS** study showed.